首页 社会内容详情
欧博手机版网址:Malaysian Genomics to undertake private placement exercise

欧博手机版网址:Malaysian Genomics to undertake private placement exercise

分类:社会

网址:

SEO查询: 爱站网 站长工具

点击直达

皇冠足球投注网www.hg9988.vip)是皇冠体育官方投注网,开放皇冠信用网代理申请、信用网会员开户,线上投注的官方平台。

Azri Azerai

KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd has proposed to undertake a private placement of up to 10% of its total number of issued shares, to third-party investors to be identified later, at an issue price to be determined later.

The genomics and biopharmaceutical specialist said the new placement shares will rank equally in all respects with existing Malaysian Genomics shares except they will not be entitled to any dividends, rights, allotments and any other forms of distribution should the entitlement date precede the relevant date of allotment and issuance of the new placement shares.

“We are proposing the private placement to raise funds mainly for the group’s future investments of which we are still exploring options and a part of the proceeds will be allocated for the purchase of equipment including IT hardware, biological safety cabinet and extraction automation for our existing and future businesses,” executive director Azri Azerai said in a statement.

,

欧博手机版网址www.aLLbet8.vip)是欧博集团的官方网站。欧博手机版网址开放Allbet注册、Allbe代理、Allbet电脑客户端、Allbet手机版下载等业务。

,

He said the reopening of the economy presents opportunities in the private healthcare segment and the fresh funds raised will enable the company to be able to take advantage of the possibilities.

“We diversified into the biopharmaceutical business in 2020 and have since been pushing to open channels for our cell therapies and genetic tests through a series of agreements that gives us a wider market reach. We also bought a 51% stake in a kidney dialysis operator, Aquahealth Sdn Bhd, to offer holistic kidney care,” he added.

UOB Kay Hian Securities (M) Sdn Bhd is the adviser and placement agent for the proposed private placement.


转载说明:本文转载自Sunbet。

发布评论